Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of cstsmlkac (disulfide) in China, also supports custom service. Welcome to wholesale bulk high quality cstsmlkac (disulfide) from our factory. Contact us for more details.
| Description | CSTMLKAC is an 8-amino acid disulfide-cyclized peptide with the sequence Cys-Ser-Thr-Met-Leu-Lys-Ala-Cys (CSTMLKAC), where a disulfide bond is formed between Cys1 and Cys8, maintaining the peptide in a cyclic conformation. This peptide mimics endogenous peptide sequences and is a cardiomyocyte-targeting peptide selected through in vivo phage display technology, which can specifically home to cardiomyocytes in the ischemic myocardium. The cyclic conformation of CSTMLKAC is maintained by the disulfide bond; this rigid cyclic structure improves the peptide's resistance to proteolytic degradation and helps maintain the optimal conformation for target receptor binding. The peptide sequence contains hydrophobic residues such as methionine (Met), leucine (Leu), and alanine (Ala), as well as polar/basic residues such as serine (Ser), threonine (Thr), and lysine (Lys), forming amphipathic characteristics that may participate in interactions with specific receptors or molecules on the cardiomyocyte surface. Applications of CSTMLKAC include: (1) ischemic myocardium-targeted imaging - after labeling with fluorescent dyes or radionuclides, used for visualization of ischemic myocardium and assessment of myocardial infarction area; (2) myocardium-targeted drug delivery - targeted delivery of therapeutic drugs, stem cells, nanoparticles, or gene therapy reagents to the ischemic myocardium to improve myocardial repair and regeneration therapy; (3) myocardial ischemia-reperfusion injury protection - targeted delivery of antioxidants, anti-inflammatory peptides, or anti-apoptotic drugs to the ischemic myocardium; (4) heart failure therapy - targeted delivery of cardioprotective drugs or gene therapy reagents to the failing myocardium; (5) cardiomyocyte biology research - as a tool peptide to study cardiomyocyte surface receptors and ischemic myocardium molecular markers. CSTMLKAC is an important tool peptide for studying myocardium-targeted delivery and developing targeted therapy strategies for cardiovascular diseases. This peptide is stored as a lyophilized powder at -20°C under dry, light-protected conditions; the disulfide bond requires attention to avoid reducing agents (e.g., DTT, β-mercaptoethanol) that could cause disulfide bond cleavage during storage and use. |
Product Basic Information Table
| Product Standard English Name | Product Abbreviation / Alias | Function Tags (comma-separated) | Core Structure | Molecular Formula | Exact Mass (Da) | Average MW (Da) | Salt Form | Length (aa) |
| CSTSMLKAC (disulfide) | Disulfide-cyclized CSTSMLKAC peptide; intramolecular disulfide nonapeptide | Disulfide cyclic peptide, receptor-binding peptide, enzyme inhibitor, protein interaction probe | Nonapeptide cyclized via intramolecular disulfide bond between terminal cysteines; forms a stable cyclic conformation, and can specifically bind target receptors or inhibit protease activity for protein interaction and inhibitor screening studies | C₃₅H₆₁N₉O₁₀S₃ | 883.37 | ~884.2 | Acetate | 9 |
Physicochemical Solubility & Storage Parameters
| Product Code | Appearance | Long-term Storage | Short-term Storage | Solution Stability | Solid Powder Stability |
| PEP-CST09 | White powder | Store at -20°C, sealed, dry and protected from light. Aliquot for storage. | Stable for 1 month at 2–8°C in sealed dry condition; stable for shipping at ambient temperature. | Stable for 7 days at 4°C. Soluble in water, dilute acetic acid and neutral buffers. Intramolecular disulfide bond is sensitive to strong reducing agents and high-concentration thiol compounds; prone to disulfide cleavage and inactivation. Avoid combination with strong reducing agents. | Stable for 2 years at -20°C, dry and protected from light. |
Functional Description
| Product Code | Frontend Short Summary (for search list display) | Detailed Biological Function Description | Applicable Research Areas (comma-separated) | Targets / Pathways |
| PEP-CST09 | Disulfide-cyclized CSTSMLKAC peptide as stable cyclic receptor binding probe | CSTSMLKAC is cyclized via an intramolecular disulfide bond between terminal cysteines, constraining the linear peptide into a stable cyclic conformation, which significantly enhances binding affinity and specificity to target receptors. It can be used as a molecular probe for protein interaction studies, or developed into protease inhibitors and receptor antagonists. | Protein interaction research, enzyme inhibitor development, receptor ligand screening, peptide drug development, structural biology research | Target receptor binding pocket; protease active site; disulfide-stabilized cyclic conformation |
Hot Tags: cstsmlkac (disulfide), China cstsmlkac (disulfide) manufacturers, suppliers, factory, 191936-91-1, 395069-92-8, 651328-78-8, CAS 395069 92 8, drug delivery peptides, MPG Peptide
